Rockefeller Capital Management L.P. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 19.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 397,062 shares of the healthcare conglomerate’s stock after purchasing an additional 65,648 shares during the quarter. UnitedHealth Group makes up 0.5% of Rockefeller Capital Management L.P.’s investment portfolio, making the stock its 25th largest holding. Rockefeller Capital Management L.P.’s holdings in UnitedHealth Group were worth $200,840,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of UNH. Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after buying an additional 319,515 shares during the last quarter. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at $6,375,744,000. Franklin Resources Inc. raised its position in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after buying an additional 861,854 shares during the last quarter. Bank of New York Mellon Corp increased its stake in UnitedHealth Group by 0.5% during the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock valued at $4,012,218,000 after acquiring an additional 36,394 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of UnitedHealth Group by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate’s stock worth $3,148,134,000 after acquiring an additional 182,361 shares during the period. Institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on UNH shares. Truist Financial boosted their price target on shares of UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a report on Friday. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Mizuho increased their target price on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Twenty-one investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $632.85.
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by insiders.
UnitedHealth Group Stock Up 0.8 %
NYSE:UNH opened at $599.10 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $548.00 billion, a price-to-earnings ratio of 38.65, a PEG ratio of 1.37 and a beta of 0.61. The stock has a 50-day moving average price of $512.87 and a two-hundred day moving average price of $542.03.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.83 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- ETF Screener: Uses and Step-by-Step Guide
- JPMorgan is a Buy, if You Can Handle The Volatility
- What is the Nikkei 225 index?
- United States Steel’s Crash: An Unmissable Buying Opportunity
- How Technical Indicators Can Help You Find Oversold Stocks
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.